Robert A. Felberg

Robert A. Felberg

Auto-generated profile, based on publicly available information

Robert A. Felberg

Department of Neurology, Ochsner Foundation Hospital, New Orleans, Louisiana, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Stroke
Verified
Journal Article
Closed access
RFRobert A. Felberg
Robert A. Felberg
NONicholas J. Okon
Nicholas J. Okon
AEAshraf El-Mitwalli
Ashraf El-Mitwalli
WBW. Scott Burgin
W. Scott Burgin
JGJames C. Grotta
James C. Grotta
AAAndrei V. Alexandrov
Andrei V. Alexandrov
Background and Purpose — Acute-stroke patients receiving standard intravenous tissue plasminogen activator (tPA) have been noted to experience early dramatic recoveries. The prevalence, clinical characteristics, and outcome of patients experiencing dramatic recovery is not well described. Methods — We prospectively studied all patients presenting with acute middle cerebral artery (MCA) stroke syndromes and transcranial Doppler (TCD) evidence of an MCA obstruction. All patients received intravenous tPA per the National Institute of Neurological and Communicative Disorders and Stroke protocol, with serial National Institutes of Health Stroke Scale (NIHSS) scores and continuous TCD monitoring. Dramatic recovery was defined as an improvement of ≥10 NIHSS points or a decrease to an NIHSS score of ≤3 by the end of infusion. Outcome at the end of infusion, at 24 hours, and at long-term follow-up were obtained. The timing and pattern of deficit recovery during dramatic recovery was also studied. Results — Dramatic recovery occurred in 22% of all patients. Compared with patients who did not experience dramatic recovery, those patients who did had significantly lower end-infusion NIHSS (median 2 and range 0 to 16 for dramatic-recovery patients versus median 17 and range 6 to 35 for non–dramatic-recovery patients, P <0.01) and 24-hour NIHSS (median 2 and range 0 to 16 for dramatic-recovery patients versus median 13 and range 2 to 35 for non–dramatic-recovery patients, P <0.01). A long-term modified Rankin Score benefit was noted (median 1 and range 0 to 6 for dramatic-recovery patients versus median 4 and range 0 to 6 for non–dramatic-recovery patients, P <0.01). Baseline clinical characteristics were similar. The only difference was improved TCD-determined flow values at the end of infusion (normal restoration of flow was 58% in dramatic-recovery patients versus 14% in non–dramatic-recovery patients, P <0.01). A characteristic pattern of recovery of deficit was noted. Conclusions — Early dramatic recovery in acute MCA stroke patients treated with intravenous tPA is relatively frequent. The benefit of dramatic recovery is maintained at 24 hours and over the long term. TCD monitoring suggests that dramatic recovery is a result of early restoration of MCA flow during the tPA infusion. The consistent pattern of early clinical recovery may help explain the mechanisms by which thrombolysis improves outcome and could suggest targets for enhancing the therapeutic effect of intravenous tPA.

1 January 2002 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
RFRobert A. Felberg
Robert A. Felberg
ICIoannis Christou
Ioannis Christou
ADAndrew M. Demchuk
Andrew M. Demchuk
MMMarc Malkoff
Marc Malkoff
AAAndrei V. Alexandrov
Andrei V. Alexandrov

30 November 1999 in Circulation
Verified
Journal Article
Closed access
PDF file
ADAndrew M. Demchuk
Andrew M. Demchuk
TWTEd wein
TEd wein
RFRobert A. Felberg
Robert A. Felberg
ICIoannis Christou
Ioannis Christou
AAAndrei V. Alexandrov
Andrei V. Alexandrov

1 April 2003 in Southern Medical Journal
Verified
Journal Article
Closed access
RFRobert A. Felberg
Robert A. Felberg
ANAndrew M. Naidech
Andrew M. Naidech
MDMd
Md
Stroke is a treatable disease. Despite the therapeutic nihilism of the past, the advent of thrombolysis has changed the way stroke is approached. Acute ischemic stroke is a challenging and heterogeneous disease. Treatment needs to be based on an understanding of the underlying pathophysiology of ischemia. Interventions are designed to improve neuronal salvage and outcome. The underlying tenets of...

15 December 2006 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
RFRobert A. Felberg
Robert A. Felberg

1 January 2001 in Journal of Child Neurology
Verified
Journal Article
Closed access
ENElizabeth Anne Noser
Elizabeth Anne Noser
RFRobert A. Felberg
Robert A. Felberg
AAAndrei V. Alexandrov
Andrei V. Alexandrov